Corrosion Inhibitors Market Size, Share & Trends Analysis Report By Product (Organic, Inorganic), By Type (Water Based, Oil Based), By End Use (Oil And Gas, Chemical Processing), By Region, And Segment Forecasts, 2025 - 2030

Corrosion Inhibitors Market Size, Share & Trends Analysis Report By Product (Organic, Inorganic), By Type (Water Based, Oil Based), By End Use (Oil And Gas, Chemical Processing), By Region, And Segment Forecasts, 2025 - 2030

Endoluminal Suturing Devices Market Growth & Trends

The global endoluminal suturing devices market size is estimated to reach USD 147.2 million by 2030, registering to grow at a CAGR of 10.1% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rapid growth can be attributed to factors such as increasing incidence of obesity and rising number of minimally invasive surgery. According to the World Health Organization (WHO), in 2016, more than 1.9 billion people aged 18 and above were overweight, out of which over 650.0 million people were obese. Furthermore, rising awareness about personal care and the availability of various weight reduction techniques will boost the market during the forecast period.

Technological advancement and the high adoption rate of endoluminal suturing devices are expected to boost market growth. In addition, the integration of robot-assisted surgery modalities in the field of gastroenterology is expected to expand the application of endoluminal procedures with high precision and reduced error. The robotic suturing technique gives surgeons a degree of freedom of robotic arm and also provide three-dimensional vision. Thus, the availability of these advance techniques is allowing doctors and surgeons to explore various applications of endoluminal surgeries. However, endoluminal suturing devices are comparatively new to the market. Only a handful of companies are making these medical devices and many new players are in a process of FDA approvals and clinical trials.

Endoluminal Suturing Devices Market Report Highlights

• The gastrointestinal surgery segment accounted for a dominant revenue share of 35.2% in 2024.
• The hospitals segment accounted for the largest revenue share in the global market in 2024.
• The gastroesophageal reflux surgery segment is expected to advance at the fastest CAGR of 10.8% during the forecast period.
• North America accounted for the largest revenue share of 43.4% in the global market in 2024 due to well-established healthcare infrastructure and high demand for advanced surgical technologies.

Please note The report will be delivered in 2-3 business days upon order notification.